Researcher
Sofie Deschoemaeker
- Keywords (Vrije Universiteit Brussel):Applied biological sciences, biotechnology
- Disciplines (Flanders Institute for Biotechnology):Analysis of next-generation sequence data, Adaptive immunology, Bacteriology
- Disciplines (Vrije Universiteit Brussel):Innate immunity, Cancer therapy
Affiliations
- Brussels Center for Immunology (Research group)
Member
From1 Jan 2023 → Today - Damya Laoui Lab
Member
From1 Oct 2022 → Today - FORMER_Cellular and Molecular Immunology (Research group)
Member
From1 Jan 2021 → 30 Sep 2022 - Department of Bio-engineering Sciences (Department)
Member
From1 May 2020 → Today - Department of Bio-engineering Sciences (Department)
Member
From1 May 2020 → 31 Dec 2020 - FORMER_Cellular and Molecular Immunology (Research group)
Member
From15 Jan 2020 → 31 Dec 2023 - FORMER_Cellular and Molecular Immunology (Research group)
Member
From15 Jan 2020 → 20 Oct 2022 - Van Ginderachter Lab
Member
From15 Jan 2020 → 30 Sep 2022
Projects
1 - 1 of 1
- Towards the rational design of cancer therapies combining tumorderived dendritic cell vaccinations with regulatory TFrom1 Nov 2022 → TodayFunding: FWO fellowships
Publications
1 - 10 of 17
- Intratumoral delivery of lipid nanoparticle-formulated mRNA encoding IL-21, IL-7, and 4-1BBL induces systemic anti-tumor immunity(2024)
Authors: Ahmed Emad Ibrahim Hamouda, Jessica Filtjens, Elisabeth Brabants, Daliya Kancheva, Ayla Debraekeleer, Jan Brughmans, Lotte Jacobs, Pauline Bardet, Elisabeth Knetemann, Pierre Lefesvre, et al.
- Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models(2023)
Authors: Emile Clappaert, Daliya Kancheva, Jan Brughmans, Ayla Debraekeleer, Pauline Bardet, Yvon Elkrim, Dagmar Lacroix, Maida Živalj, Ahmed Emad Ibrahim Hamouda, Jo A Van Ginderachter, et al.
- Efficacy of CD40 agonists is mediated by distinct cDC subsets and subverted by suppressive macrophages(2022)
Authors: Aleksandar Murgaski, Máté Kiss, Helena Van Damme, Daliya Kancheva, Isaure Vanmeerbeek, Jiri Keirsse, Eva Hadadi, Jan Brughmans, Sana Arnouk, Ahmed Emad Ibrahim Hamouda, et al.
Pages: 3785-3801 - Dendritic Cell Vaccines: A Promising Approach in the Fight against Ovarian Cancer(2022)
Authors: Aarushi Audhut Caro, S. Deschoemaeker, Lize Allonsius, An Coosemans, Damya Laoui
- In Vivo Identification of Adducts from the New Hypoxia-Activated Prodrug CP-506 Using DNA Adductomics(2022)
Authors: Morwena J Solivio, Alessia Stornetta, Julie Gilissen, Peter W Villalta, Sofie Deschoemaeker, Arne Heyerick, Ludwig J Dubois, Silvia Balbo
Pages: 275-282 - Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions(2022)
Authors: Emma Verheye, Jesús Bravo Melgar, S. Deschoemaeker, G Raes, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Damya Laoui, Kim De Veirman
- Heterogeneity and function of macrophages in the breast during homeostasis and cancer(2022)Series: International Review of Cell and Molecular Biology
Authors: Eva Hadadi, S. Deschoemaeker, Gerard Vicente Venegas, Damya Laoui
Pages: 149-182Number of pages: 34 - Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506(2021)
Authors: Alexander M A van der Wiel, Victoria Jackson-Patel, Raymon Niemans, Ala Yaromina, Emily Liu, Damiënne Marcus, Alexandra M Mowday, Natasja G Lieuwes, Rianne Biemans, Xiaojing Lin, et al.
Pages: 2372-2383 - IFNγ signaling response in peripheral blood monocytes: A new prognostic biomarker for breast cancer?(2020)
Authors: Sofie Deschoemaeker, Damya Laoui
Pages: 102690 - Impact of myo-inositol trispyrophosphate (ITPP) on tumour oxygenation and response to irradiation in rodent tumour models.(2018)
Authors: Le Nam Tra Tran, TT Cao-Pham, B.f. Jordan, S. Deschoemaeker, A Heyerick, Bernard Gallez
Pages: 1908-1916